Invitation - Presentation of Sobi's Q3 2020 results
STOCKHOLM, Oct. 7, 2020 /PRNewswire/ -- On 22 October, at 08:00 CET, Swedish Orphan Biovitrum AB (publ) (Sobi™) will publish its report for the third quarter 2020. Investors, financial analysts and media are invited to participate in a telephone conference, which will include a presentation of the results, on the same day at 13:00 CEST. The event will be hosted by Sobi's CEO and President, Guido Oelkers, and the presentation will be held in English.
The presentation can be followed live, or afterwards on www.sobi.com. Slides used in the presentation will be made available on Sobi's website prior to the telephone conference.
To participate in the telephone conference, please call:
After the live event the webcast will be available on-demand via the same link.
Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases. Sobi is providing sustainable access to innovative therapies in the areas of haematology, immunology and specialty indications. Today, Sobi employs approximately 1,400 people across Europe, North America, the Middle East, Russia and North Africa. In 2019, Sobi's revenue amounted to SEK 14.2 billion. Sobi's share (STO: SOBI) is listed on Nasdaq Stockholm. You can find more information about Sobi at www.sobi.com.
For more information please contact
Paula Treutiger, Head of Communication & Investor Relations
Linda Holmström, Corporate Communication & Investor Relations
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Invitation to presentation of Q3 2020 report
SOURCE Swedish Orphan Biovitrum AB
Company Codes: Berlin:B6E, Bloomberg:SOBI@SS, ISIN:SE0000872095, LSE:0MTD, OTC-PINK:BIOVF, RICS:SOBI.ST, Stockholm:SOBI, Dusseldorf:B6E, Frankfurt:B6E, Munich:B6E, Stuttgart:B6E